Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2010-N-0511]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of eight new animal drug applications (NADAs). In a final rule published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is amending the animal drug regulations to remove portions reflecting approval of these NADAs.
 DATES: Withdrawal of approval is effective November 5, 2010.
 FOR FURTHER INFORMATION CONTACT: John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, e-mail: 
                        *john.bartkowiak@fda.hhs.gov.*


SUPPLEMENTARY INFORMATION: Fort Dodge Animal Health, a Division of Wyeth Holdings, a Wholly Owned Subsidiary of Pfizer, Inc., 235 East 42d 
                    ( print page 65643)
                    St., New York, NY 10017 has requested that FDA withdraw approval of the eight NADAs listed in Table 1 of this document. Table 1
NADA No.
Product
Established name of drug(s)NADA 11-141
UNISTAT-2 Type A medicated article
nitromide and sulfanitranNADA 14-250
NOVASTAT Type A medicated article
aklomide and sulfanitranNADA 34-536
ALKOMIX Type A medicated article
                             ALKOMIX-3 Type A medicated article
aklomide
                             aklomide, sulfanitran, and roxarsoneNADA 34-537
NOVASTAT-3 Type A medicated article
aklomide, sulfanitran, and roxarsoneNADA 35-388
NOVASTAT-W Soluble Powder
aklomide and sulfanitranNADA 39-666
UNISTAT-3 Type A medicated article
nitromide, sulfanitran, and roxarsoneNADA 44-015
TRAMISOL Type A medicated article
levamisoleNADA 45-455
TRAMISOL Type A medicated article
levamisole
 Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with § 514.116 
                    *Notice of withdrawal of approval of application*
                     (21 CFR 514.116), notice is given that approval of NADAs 11-141, 14-250, 34-536, 34-537, 35-388, 39-666, 44-015, and 45-455, and all supplements and amendments thereto, is hereby withdrawn, effective November 5, 2010. In a final rule published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs. Dated: October 8, 2010. Bernadette Dunham, Director, Center for Veterinary Medicine.


[FR Doc. 2010-27010 Filed 10-25-10; 8:45 am] BILLING CODE 4160-01-P